361 related articles for article (PubMed ID: 23875703)
1. Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.
Yang YY; Lee PC; Huang YT; Lee WP; Kuo YJ; Lee KC; Hsieh YC; Lee TY; Lin HC
Clin Sci (Lond); 2014 Jan; 126(2):163-74. PubMed ID: 23875703
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1alpha protects the liver against ischemia-reperfusion injury by regulating the A2B adenosine receptor.
Zhang X; Du P; Luo K; Li Y; Liu Z; Wang W; Zeng C; Ye Q; Xiao Q
Bioengineered; 2021 Dec; 12(1):3737-3752. PubMed ID: 34288817
[TBL] [Abstract][Full Text] [Related]
3. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
Yang YY; Huang YT; Tsai TH; Hou MC; Lee FY; Lee SD; Lin HC
Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967
[TBL] [Abstract][Full Text] [Related]
4. Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice.
Lehwald N; Tao GZ; Jang KY; Sorkin M; Knoefel WT; Sylvester KG
Gastroenterology; 2011 Aug; 141(2):707-18, 718.e1-5. PubMed ID: 21679710
[TBL] [Abstract][Full Text] [Related]
5. Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD.
Wang CH; Liu HM; Chang ZY; Huang TH; Lee TY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360607
[TBL] [Abstract][Full Text] [Related]
6. Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury.
Li TH; Liu CW; Lee PC; Huang CC; Lee KC; Hsieh YC; Yang YY; Hsieh SL; Lin HC; Tsai CY
J Chin Med Assoc; 2017 Jul; 80(7):391-400. PubMed ID: 28325574
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury.
Wang ZY; Liu Y; Li SP; Li JJ; Zhang Z; Xiao XC; Ou Y; Wang H; Cai JZ; Yang S
World J Gastroenterol; 2022 Oct; 28(38):5573-5588. PubMed ID: 36304082
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor-α promotes liver ischaemia-reperfusion injury through the PGC-1α/Mfn2 pathway.
Li J; Ke W; Zhou Q; Wu Y; Luo H; Zhou H; Yang B; Guo Y; Zheng Q; Zhang Y
J Cell Mol Med; 2014 Sep; 18(9):1863-73. PubMed ID: 24898700
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.
Yang YY; Huang YT; Lee TY; Chan CC; Yeh YC; Lee KC; Lin HC
Liver Transpl; 2012 Nov; 18(11):1371-83. PubMed ID: 22847887
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice.
Liu X; Huang K; Niu Z; Mei D; Zhang B
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):144-153. PubMed ID: 30180301
[TBL] [Abstract][Full Text] [Related]
11. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
El-Derany MO; El-Demerdash E
Biochem Pharmacol; 2020 Jul; 177():113942. PubMed ID: 32240652
[TBL] [Abstract][Full Text] [Related]
12. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury.
Teoh NC; Williams J; Hartley J; Yu J; McCuskey RS; Farrell GC
Hepatology; 2010 Mar; 51(3):996-1006. PubMed ID: 20131406
[TBL] [Abstract][Full Text] [Related]
13. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
[TBL] [Abstract][Full Text] [Related]
14. Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.
Cui Y; Guo C; Xia Z; Xue Y; Song B; Hu W; He X; Liang S; Wei Y; Zhang C; Wang H; Xu D; Zhang S; Fang J
Acta Biomater; 2023 Oct; 169():500-516. PubMed ID: 37574157
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
Ji G; Wang Y; Deng Y; Li X; Jiang Z
Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332
[TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: HIF-1α attenuates liver ischemia-reperfusion injury.
Guo Y; Feng L; Zhou Y; Sheng J; Long D; Li S; Li Y
Transplant Rev (Orlando); 2015 Jul; 29(3):127-34. PubMed ID: 26007634
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment with FK506 reduces hepatic ischemia-reperfusion injury in rats.
Chen F; Zhang YM; Wang JT; Wang J; Cui ZL; Liu ZR
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):161-170. PubMed ID: 30713033
[TBL] [Abstract][Full Text] [Related]
18. Treatment with geraniol ameliorates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in rats.
Chen J; Fan X; Zhou L; Gao X
J Gastroenterol Hepatol; 2016 Jul; 31(7):1357-65. PubMed ID: 26695085
[TBL] [Abstract][Full Text] [Related]
19. [Protective effect of minocycline on hepatic ischemia-reperfusion injury in rats].
Li Y; Li T; Qi H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 39(11):1137-44. PubMed ID: 25432370
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
Tian F; Zhang YJ; Li Y; Xie Y
PLoS One; 2014; 9(1):e83819. PubMed ID: 24404139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
